About the Department of Basic and Clinical Neuroscience
The Department of Basic and Clinical Neuroscience is working to improve therapeutic options for people with neurological and psychiatric disorders and inspire the next generation of neuroscientists. Our vision is to link biological and clinical research to gain a better understanding of fundamental disease mechanisms, identify novel opportunities for intervention and test out new therapies. We believe this can only be achieved through scientists and clinicians collaborating to work on common problems.
Ammar Al-Chalabi is the Head of Department. The Department hosts approximately twenty professors and an exceptionally strong team of lecturers, senior lecturers and readers in the disciplines of neurology, neurosurgery, neuropathology, neurophysiology, neurobiology of mental health, developmental neurobiology, molecular neuroscience and human genetics. The total staff complement including clinical and biomedical researchers, clerical and support staff comprises around 250 individuals.
The Maurice Wohl Clinical Neuroscience Institute will provide a wide range of cutting-edge research technologies. We are driving research that will translate molecular discoveries made in the laboratory into therapies for our patients. There has never been a more exciting time to be involved in neuroscience research at Kings.
Learn more about research at the Department of Basic and Clinical Neuroscience.
Working with the NHS
We are closely linked to the departments of clinical neuroscience at King’s College and Guy’s and St Thomas’ hospitals where there are approximately 90 consultants in a comprehensive range of neuroscience disciplines. These two NHS foundation trusts, together with South London and Maudsley NHS Foundation Trust, have joined King’s College London to form King’s Health Partners – one of the UK’s five academic health science centres. It's one of the largest neurological centres in the UK, serving around four million people. With these partners we run a successful programme of clinical trials in partnership with many pharmaceutical companies.
The Department of Health has recently awarded over £53.3m in funding over the next five years to the Biomedical Research Centre (BRC) for Mental Health and the new Biomedical Research Unit for Dementia (BRU-D) at King’s College London, representing the biggest percentage uplift in funding awarded to any National Institute for Health Research (NIHR) centre.